EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis
Open accessThe DOI matches its Crossref record.
Abstract
Objectives: Cancer stem cells (CSC s) compose a subpopulation of cells within a tumour that can self‐renew and proliferate. Growth factors such as epidermal growth factor (EGF) and basic fibroblast growth factor (b‐FGF) promote cancer stem cell proliferation in many solid tumours. This study assesses whether EGF, b FGF and IGF signalling pathways are essential for colon CSC proliferation and self‐renewal. Material and methods: Colon CSC s were cultured in serum‐free medium (SFM) with one of the following growth factors: EGF, b FGF or IGF. Characteristics of CSC gene expression were evaluated by real time PCR. Tumourigenicity of CSC s was determined using a xenograft model in vivo. Effects of EGF receptor inhibitors, Gefitinib and PD 153035, on CSC proliferation, apoptosis and signalling were evaluated using fluorescence‐activated cell sorting and western blotting. Results: Colon cancer cell HCT 116 transformed to CSC s in SFM. Compared to other growth factors, EGF was essential to support proliferation of CSC s that expressed higher levels of progenitor genes (Musashi‐1, LGR 5) and lower levels of differential genes (CK20). CSC s promoted more rapid tumour growth than regular cancer cells in xenografts. EGFR inhibitors suppressed proliferation and induced apoptosis of CSC s by inhibiting autophosphorylation of EGFR and downstream signalling proteins, such as Akt kinase, extracellular signal‐regulated kinase 1/2 (ERK 1/2). Conclusions: This study indicates that EGF signalling was essential for formation and maintenance of colon CSC s. Inhibition of the EGF signalling pathway may provide a useful strategy for treatment of colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Cancer stem cells: A review from origin to therapeutic implications
Atashzar, M. R., Baharlou, R., Karami, J., Abdollahi, H., Rezaei, R., Pourramezan, F., & Zoljalali Moghaddam, S. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29044 · Cited by 281
The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
Das, P. K., Islam, F., & Lam, A. K. (2020) · Cells · doi:10.3390/cells9061392 · Cited by 210
Bai, Y., Shang, K., Chen, H., Ding, F., Wang, Z., Liang, C., Xu, Y., Sun, M., & LI, Y. (2015) · Cancer Science · doi:10.1111/cas.12745 · Cited by 109
Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology
László, L., Kurilla, A., Takács, T., Kudlik, G., Koprivanacz, K., Buday, L., & Vas, V. (2021) · Cells · doi:10.3390/cells10030667 · Cited by 58
Metadata
- Authors
- Feng, Y., Dai, X., Li, X., Wang, H., Liu, J., Zhang, J., Du, Y., & Xia, L.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2012-08-27
- Volume
- 45
- Issue
- 5
- Pages
- 413-419
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W2018385059
- Cited by
- 83
- References
- 0
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. https://app.cochat.ai/papers/10.1111/j.1365-2184.2012.00837.x
- The paper
- Feng, Y., Dai, X., Li, X., Wang, H., Liu, J., Zhang, J., Du, Y., & Xia, L. (2012). EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Proliferation. https://doi.org/10.1111/j.1365-2184.2012.00837.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.